MiniMed Group, Inc. splits its revenue into 4 lines in its filings. The largest line in fiscal 2026, which ended Apr 24, 2026 was Continuous Glucose Monitoring Systems CGM at $1.6 billion, 50% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2027
Jul 31, 2026
|
FY 2026
Apr 24, 2026
|
|---|---|---|
| Revenue |
—
|
3,102
|
| Continuous Glucose Monitoring Systems CGM |
—
|
1,553
share 50.1%
|
| Consumables |
—
|
956
share 30.8%
|
| Pumps |
—
|
546
share 17.6%
|
| Product And Service Other |
—
|
46
share 1.5%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- MMED (Nasdaq), MMEDV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Northridge, CA
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 2062583
- Former names
- MDT Sub Holdings, Inc. (until May 30, 2025)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.